U.S. Other Utilities Stock News

American Airlines Group (NasdaqGS:AAL) is dealing with flight disruptions linked to escalating conflict in the Middle East, affecting routes and capacity in the region. Recent spikes in oil prices are pressuring the airline's fuel bill, with the impact amplified by the company’s lack of fuel hedging and existing financial leverage. Analysts have issued downgrades that cite these operational and cost risks, adding to investor concern about the company’s profitability outlook. American...

Wondering if Moody's current share price lines up with its underlying worth, or if the market is mispricing it right now? This article walks through the numbers so you can judge the value story for yourself. The stock last closed at US$470.05, with returns of a 2.0% decline over 7 days, a 0.2% decline over 30 days, a 5.8% decline year to date, 0.8% over 1 year, 63.3% over 3 years and 68.1% over 5 years. This gives a mixed picture of short term softness and longer term strength. Recent...

If you are wondering whether Nomad Foods at US$10.33 is starting to look like value or a value trap, you are not alone. That is exactly what this article will unpack. The stock has seen an 8.3% decline over the last week, an 18.0% drop over the past month, and is down 47.0% over the past year, putting long term holders under pressure and raising fresh questions about risk and return. Recent coverage has focused on how prolonged share price weakness and earlier acquisition activity have...

Shelf registration puts UnitedHealth’s funding options in focus UnitedHealth Group (UNH) has filed an omnibus shelf registration covering debt, preferred stock, common stock, and warrants. The filing puts fresh attention on how the company might adjust its capital structure as it works through recent operating and regulatory challenges. See our latest analysis for UnitedHealth Group. At a share price of US$288.77, UnitedHealth’s 90 day share price return of 12.73% and year to date share price...

Johnson Controls International (NYSE:JCI) has agreed to acquire Alloy Enterprises to expand its data center thermal management capabilities. The deal is aimed at strengthening Johnson Controls' position in advanced cooling solutions as data center demand increases. The acquisition focuses on adding new technology for more efficient thermal management across data-centric infrastructure. Johnson Controls International, trading on the NYSE under ticker JCI, is moving to deepen its presence in...

Ambiq Micro (AMBQ) just closed out FY 2025 with Q4 revenue of US$20.7 million and a basic EPS loss of US$0.58, alongside net income excluding extra items of a US$10.7 million loss, putting profitability squarely in focus for investors. The company has seen quarterly revenue hover in the mid to high teens over the past year, from US$15.7 million in Q1 FY 2025 to US$18.2 million in Q3, while basic EPS losses ranged from US$18.96 in Q1 FY 2025 to US$26.40 in Q4 FY 2024 before landing at US$0.58...

If you are wondering whether Blackbaud's current share price reflects its real worth, you are not alone. This article is set up to help you weigh what you are paying against what you might be getting. Over the short term the stock has seen relatively small moves, with a 1.0% return over 7 days and 1.5% over 30 days, while year to date it is down 17.2% and over 1 year it is down 23.7%. These figures may influence how you think about both risk and potential reward. Recent headlines around...

Vericel Corporation recently received U.S. Food and Drug Administration approval to begin commercial manufacturing of its MACI cartilage repair therapy at a new cell therapy facility in Burlington, Massachusetts, enabling production to start in the second quarter of 2026. This expansion of MACI manufacturing capacity is important because it supports higher volumes for knee cartilage repair and lays groundwork for potential international commercialization. Next, we’ll explore how FDA approval...

Marvell Technology, Inc. has reported past fourth-quarter 2026 revenue of US$2,218.7 million and net income of US$396.1 million, with full-year revenue of US$8.19 billion and net income of US$2.67 billion, and issued first-quarter fiscal 2027 guidance calling for about US$2.40 billion in net revenue and GAAP diluted EPS of roughly US$0.31. Alongside these results, Marvell unveiled new 2nm coherent DSPs and 1.6T ZR/ZR+ optical modules aimed at AI data center connectivity, reinforcing its...

Phillips 66 (PSX) has come into focus after lifting its quarterly dividend to $1.27 per share and outlining plans to improve refining feedstock costs through potential Venezuelan crude purchases, as oil prices and refining margins tighten. See our latest analysis for Phillips 66. The dividend move comes on top of strong recent price momentum, with a 19.4% 3 month share price return and a 27.5% year to date share price return, while the 5 year total shareholder return of 129.9% points to solid...

If you are wondering whether Estée Lauder Companies at around US$95.87 is a bargain or a value trap, you are not alone. This article is aimed at helping you frame that question clearly. The stock has seen a mixed run, with a 14.3% decline over the last 7 days and a 17.5% decline over the last 30 days. Yet a 36.1% gain over the past year sits against 3 year and 5 year returns of 58.4% and 64.6% declines respectively. Recent headlines have focused on Estée Lauder Companies as a key global...

SBA Communications (SBAC) has drawn fresh attention after recent trading data showed a gain of about 9% over the past month, prompting investors to reassess the tower REIT’s current valuation and fundamentals. See our latest analysis for SBA Communications. That recent 8.9% 30 day share price return contrasts with a 1 year total shareholder return of about an 8.7% decline, which suggests that momentum has picked up recently even though longer term holders are still behind. If SBA...

If you are wondering whether Primoris Services is still good value after its strong run, you are not alone. This article focuses squarely on what you are paying for each dollar of the business. The share price recently closed at US$137.91, with returns of 117.8% over 1 year and 5.6% year to date, and pullbacks of 9.3% over 7 days and 11.0% over 30 days that hint at shifting views on both upside and risk. Recent coverage of Primoris Services has focused on its position within the US capital...

Generate Biomedicines completed its U.S. IPO and began trading on Nasdaq under the symbol GENB. The company adopted a new certificate of incorporation in connection with its transition to public status. Generate Biomedicines joined the NASDAQ Composite Index following the offering. The IPO involved a substantial capital raise intended to support the company’s future plans. Generate Biomedicines, now trading as NasdaqGS:GENB, has moved into the public markets with a current share price of...

Micron Technology (MU) is back in focus after a sharp sector wide selloff tied to fears of higher energy costs and Iran related tensions, which pressured memory names despite ongoing AI centric demand stories. See our latest analysis for Micron Technology. Despite the latest pullback tied to energy concerns and geopolitical tensions, Micron’s recent share price performance has been strong, with a 90 day share price return of 67.38% and a very large 1 year total shareholder return of 328.52%...

Insider buying puts Vornado Realty Trust (VNO) back in focus Recent filings show Director Daniel R Tisch buying 155,000 Vornado Realty Trust (VNO) shares across several late February and early March trades, lifting his direct holdings to 185,000 shares. This cluster of insider purchases, set against mixed analyst opinions and recent share price pressure, gives investors fresh information to weigh as they assess Vornado’s office- and retail-focused REIT portfolio. See our latest analysis for...

Leidos Holdings (LDOS) is back in focus after the U.S. Air Force formally designated its Small Cruise Missile as the AGM-190A, with investors weighing what this recognition could mean for long-term contract visibility. See our latest analysis for Leidos Holdings. Recent defense contract wins and the DODNet rollout have arrived during a pullback, with a 30 day share price return of a 7.45% decline and a year to date share price return of a 4.26% decline. However, the 1 year total shareholder...

If you are wondering whether Walmart's share price still offers value after a long run, this article walks through what the current market price might be implying about the company. Walmart closed at US$123.31, with a 0.9% decline over 7 days, a 3.4% decline over 30 days, a 9.4% gain year to date and a 31.5% return over the last year, while the 3 year and 5 year returns are both very large. Recent headlines around Walmart have focused on its role as a major US retailer and its scale in key...

Why Acadia Realty Trust Is On Investors’ Radar Acadia Realty Trust (AKR) has drawn fresh attention after recent trading saw the stock up around 7% over the past month and roughly 9% in the past 3 months. For real estate investors watching listed retail landlords, those moves, combined with Acadia’s latest annual figures, raise questions about how its income profile, balance between revenue and net income, and current valuation might fit into a diversified income focused portfolio. See our...

Korn Ferry (NYSE:KFY) has approved a significant increase in its quarterly cash dividend. The higher payout will apply to upcoming dividend distributions following the board’s decision. This move directly affects income for shareholders who hold NYSE:KFY. The dividend hike comes as Korn Ferry shares trade around $65.08, with the stock up 3.4% over the past week and showing a 22.7% return over the past 3 years. The company’s value score of 6 may be relevant to investors who focus on...

Deutsche Bank’s upgrade of Dauch (DCH) from Hold to Buy, together with a shift in consensus brokerage views to Outperform, has put the stock back on many investors’ radars this week. See our latest analysis for Dauch. Even with Deutsche Bank’s upgrade and the recent RSU grants tied to the Dowlais combination, Dauch’s 1 month share price return of 28.95% and 7 day share price return of 13.74% indicate momentum has cooled recently. However, its 1 year total shareholder return of 21.92%...

In recent months, Crane NXT reported solid operating results and advanced the first phase of its Antares Vision acquisition, while also facing a reduced full-year earnings outlook amid renewed trade tensions with China and macro uncertainty in its Payment Innovations segment. This combination of cautious guidance and geopolitical risk contrasts with ongoing momentum in Security & Authentication Technologies and an expansion into life sciences and food & beverage markets, creating a more...

TG Therapeutics (TGTX) is back in focus after management reaffirmed its 2026 revenue guidance for BRIUMVI, highlighted rapid physician uptake in multiple sclerosis, and noted a busy schedule of pipeline readouts in the coming years. See our latest analysis for TG Therapeutics. Despite strong 2025 results and the recent azer cel milestone, TG Therapeutics’ 7 day share price return of 6.05% and 90 day share price return of 5.62% point to fading near term momentum, while the 3 year total...

Without a specific news headline driving attention today, Diamondback Energy (FANG) is on investors’ radar as an established Permian Basin producer with shares recently closing at $179.04 and a one year total return of 31.47%. See our latest analysis for Diamondback Energy. The recent 7.22% 7 day share price return and 9.92% 30 day share price return hint that positive momentum is building on top of a 31.47% 1 year total shareholder return and stronger multi year gains. If Diamondback’s run...